Works matching IS 14655411 AND DT 2020 AND VI 22 AND IP 1


Results: 138
    1
    2
    3

    Shotgun proteomics coupled to nanoparticle-based biomarker enrichment reveals a novel panel of extracellular matrix proteins as candidate serum protein biomarkers for early-stage breast cancer detection.

    Published in:
    2020
    By:
    • Fredolini, Claudia;
    • Pathak, Khyatiben V.;
    • Paris, Luisa;
    • Chapple, Kristina M.;
    • Tsantilas, Kristine A.;
    • Rosenow, Matthew;
    • Tegeler, Tony J.;
    • Garcia-Mansfield, Krystine;
    • Tamburro, Davide;
    • Zhou, Weidong;
    • Russo, Paul;
    • Massarut, Samuele;
    • Facchiano, Francesco;
    • Belluco, Claudio;
    • De Maria, Ruggero;
    • Garaci, Enrico;
    • Liotta, Lance;
    • Petricoin, Emanuel F.;
    • Pirrotte, Patrick
    Publication type:
    journal article
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    15
    16
    17
    18
    19

    Immuno-priming durvalumab with bevacizumab in HER2-negative advanced breast cancer: a pilot clinical trial.

    Published in:
    2020
    By:
    • Quintela-Fandino, Miguel;
    • Holgado, Esther;
    • Manso, Luis;
    • Morales, Serafin;
    • Bermejo, Begoña;
    • Colomer, Ramon;
    • Apala, Juan V.;
    • Blanco, Raquel;
    • Muñoz, Manuel;
    • Caleiras, Eduardo;
    • Iranzo, Vega;
    • Martinez, Mario;
    • Dominguez, Orlando;
    • Hornedo, Javier;
    • Gonzalez-Cortijo, Lucia;
    • Cortes, Javier;
    • Gasol Cudos, Ariadna;
    • Malon, Diego;
    • Lopez-Alonso, Antonio;
    • Moreno-Ortíz, María C.
    Publication type:
    journal article
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30

    Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer-results from the randomized phase III SUCCESS-A trial.

    Published in:
    2020
    By:
    • de Gregorio, Amelie;
    • Häberle, Lothar;
    • Fasching, Peter A.;
    • Müller, Volkmar;
    • Schrader, Iris;
    • Lorenz, Ralf;
    • Forstbauer, Helmut;
    • Friedl, Thomas W. P.;
    • Bauer, Emanuel;
    • de Gregorio, Nikolaus;
    • Deniz, Miriam;
    • Fink, Visnja;
    • Bekes, Inga;
    • Andergassen, Ulrich;
    • Schneeweiss, Andreas;
    • Tesch, Hans;
    • Mahner, Sven;
    • Brucker, Sara Y.;
    • Blohmer, Jens-Uwe;
    • Fehm, Tanja N.
    Publication type:
    journal article
    31
    32
    33

    Haplotype analysis of the internationally distributed BRCA1 c.3331_3334delCAAG founder mutation reveals a common ancestral origin in Iberia.

    Published in:
    2020
    By:
    • Tuazon, Anna Marie De Asis;
    • Lott, Paul;
    • Bohórquez, Mabel;
    • Benavides, Jennyfer;
    • Ramirez, Carolina;
    • Criollo, Angel;
    • Estrada-Florez, Ana;
    • Mateus, Gilbert;
    • Velez, Alejandro;
    • Carmona, Jenny;
    • Olaya, Justo;
    • Garcia, Elisha;
    • Polanco-Echeverry, Guadalupe;
    • Stultz, Jacob;
    • Alvarez, Carolina;
    • Tapia, Teresa;
    • Ashton-Prolla, Patricia;
    • Brazilian Familial Cancer Network;
    • Alemar, Barbara;
    • Netto, Cristina Brinckmann Oliveira
    Publication type:
    journal article
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47

    Targetable ERBB2 mutation status is an independent marker of adverse prognosis in estrogen receptor positive, ERBB2 non-amplified primary lobular breast carcinoma: a retrospective in silico analysis of public datasets.

    Published in:
    2020
    By:
    • Kurozumi, Sasagu;
    • Alsaleem, Mansour;
    • Monteiro, Cíntia J.;
    • Bhardwaj, Kartikeya;
    • Joosten, Stacey E. P.;
    • Fujii, Takaaki;
    • Shirabe, Ken;
    • Green, Andrew R.;
    • Ellis, Ian O.;
    • Rakha, Emad A.;
    • Mongan, Nigel P.;
    • Heery, David M.;
    • Zwart, Wilbert;
    • Oesterreich, Steffi;
    • Johnston, Simon J.
    Publication type:
    journal article
    48
    49
    50